BER launches Environmental System Science Program. Visit our new website under construction!

U.S. Department of Energy Office of Biological and Environmental Research

BER Research Highlights

Neutron Crystallography Shows How Drugs Bind to Enzymes
Published: August 28, 2012
Posted: December 04, 2012

more..." />
Complementarity of Neutron and X-Ray Data. Ball-and-stick figure of AZM and zinc (magenta sphere) in the HCA II active site. Heavier sulfur atoms (red) are clearly visible in the electron density map (blue; contoured at 2.0 s), while light deuterium atoms (cyan) are visible in the nuclear density map (yellow; contoured at 1.5 s).
Image credit: Los Alamos National Laboratory

X-ray crystallography is commonly used to determine how the atoms comprising a biological macromolecule are arranged. However, it has one serious limitation: it cannot observe directly where all of the hydrogen atoms are located, because they scatter x-rays very weakly (or in the case of H+, not at all). This underscores a major weakness of x-ray crystallography since an enzyme’s behavior usually depends on the arrangement of hydrogen atoms around its active site. In contrast, neutron crystallography can reveal the position of hydrogen atoms since they scatter neutrons as strongly as the other atoms found in proteins (i.e., C, N, O, and S). A recent study used neutron crystallography to show how carbonic anhydrase (HCA), an enzyme found in all life forms, binds acetazolamide (AZM), a carbonic anhydrase inhibitor drug clinically used to treat disorders ranging from glaucoma to epilepsy to altitude sickness. Experiments at the Protein Crystallography Station at Los Alamos National Laboratory (LANL) identified the hydrogen atoms at the binding site. The results clearly show the ionization state of AZM and how drug binding displaces key active site water molecules in HCA. It also revealed the hydrogen bonding interactions between the drug and the enzyme and showed the role of certain water molecules in drug binding. The experiments demonstrate that neutron beams provide crucial and specific information that will assist in applications such as structure-based drug design. The research was carried out by scientists at LANL and the University of Florida.

Reference: Fisher, S. Z., M. Aggarwal, A. Y. Kovalevsky, D. N. Silverman, and R. McKenna. 2012. “Neutron Diffraction of Acetazolamide-Bound Human Carbonic Anhydrase II Reveals Atomic Details of Drug Binding,” Journal of the American Chemical Society 134(36), 14726-729.  DOI: 10.1021/ja3068098. (Reference link).

Contact: Roland F. Hirsch, SC-23.2, (301) 903-9009
Topic Areas:

  • Research Area: Structural Biology, Biomolecular Characterization and Imaging
  • Research Area: Structural Biology Infrastructure

Division: SC-33.2 Biological Systems Science Division, BER


BER supports basic research and scientific user facilities to advance DOE missions in energy and environment. More about BER

Recent Highlights

Jan 11, 2022
No Honor Among Copper Thieves
Findings provide a novel means to manipulate methanotrophs for a variety of environmental and in [more...]

Dec 06, 2021
New Genome Editing Tools Can Edit Within Microbial Communities
Two new technologies allow scientists to edit specific species and genes within complex laborato [more...]

Oct 27, 2021
Fungal Recyclers: Fungi Reuse Fire-Altered Organic Matter
Degrading pyrogenic (fire-affected) organic matter is an important ecosystem function of fungi i [more...]

Oct 19, 2021
Microbes Offer a Glimpse into the Future of Climate Change
Scientists identify key features in microbes that predict how warming affects carbon dioxide emi [more...]

Aug 25, 2021
Assessing the Production Cost and Carbon Footprint of a Promising Aviation Biofuel
Biomass-derived DMCO has the potential to serve as a low-carbon, high-performance jet fuel blend [more...]

List all highlights (possible long download time)